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Abstract 
Current models of progression in neurodegenerative diseases use neuroimaging 
measures that are averaged across pre-defined regions of interest (ROIs). Such 
models are unable to recover fine details of atrophy patterns; they tend to impose an 
assumption of strong spatial correlation within each ROI and no correlation among 
ROIs. Such assumptions may be violated by the influence of underlying brain 
network connectivity on pathology propagation – a strong hypothesis e.g. in 
Alzheimer’s Disease. Here we present DIVE: Data-driven Inference of Vertexwise 
Evolution. DIVE is an image-based disease progression model with single-vertex 
resolution, designed to reconstruct long-term patterns of brain pathology from short-
term longitudinal data sets. DIVE clusters vertex-wise (i.e. point-wise) biomarker 
measurements on the cortical surface that have similar temporal dynamics across a 
patient population, and concurrently estimates an average trajectory of vertex 
measurements in each cluster. DIVE uniquely outputs a parcellation of the cortex into 
areas with common progression patterns, leading to a new signature for individual 
diseases. DIVE further estimates the disease stage and progression speed for every 
visit of every subject, potentially enhancing stratification for clinical trials or 
management. On simulated data, DIVE can recover ground truth clusters and their 
underlying trajectory, provided the average trajectories are sufficiently different 
between clusters. We demonstrate DIVE on data from two cohorts: the Alzheimer's 
Disease Neuroimaging Initiative (ADNI) and the Dementia Research Centre (DRC), 
UK. The DRC cohort contains patients with Posterior Cortical Atrophy (PCA) as well 
as typical Alzheimer's disease (tAD). DIVE finds similar spatial patterns of atrophy 
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for tAD subjects in the two independent datasets (ADNI and DRC), and further 
reveals distinct patterns of pathology in different diseases (tAD vs PCA) and for 
distinct types of biomarker data – cortical thickness from Magnetic Resonance 
Imaging (MRI) vs amyloid load from Positron Emission Tomography (PET). We 
demonstrate that DIVE stages have potential clinical relevance, despite being based 
only on imaging data, by showing that the stages correlate with cognitive test scores. 
Finally, DIVE can be used to estimate a fine-grained spatial distribution of pathology 
in the brain using any kind of voxelwise or vertexwise measures including Jacobian 
compression maps, fractional anisotropy (FA) maps from diffusion tensor imaging 
(DTI) or other PET measures.  
 
DIVE availability: DIVE source code, written in Python3, is available at 
https://github.com/mrazvan22/dive and can be easily applied on any registered 
voxelwise images or images processed with the Freesurfer software. ADNI data can 
be downloaded from the Laboratory of NeuroImaging at the University of Southern 
California. 
 
1 Introduction 
 
Many biomarkers exist that can be used to track the severity of neurodegenerative 
diseases such as Alzheimer's disease (AD). Clinical function can be measured using 
cognitive assessments performed by an expert clinician and brain atrophy can be 
measured using Magnetic Resonance Imaging (MRI). Other measures include 
molecular markers such as aggregation of misfolded amyloid-beta or tau measured 
using Positron Emission Tomography (PET), and measures of white-matter 
degradation such as fractional anisotropy (FA) from Diffusion Tensor Imaging (DTI). 
The evolution of these biomarkers across the disease time-course creates a unique 
signature of the disease that can be used to stage patients, which is helpful for 
stratification in clinical trials.  
 
A hypothetical model of disease progression has been proposed by (Jack Jr et al., 
2010), describing the order of abnormality of key biomarkers along the progression 
of AD. The model suggests that amyloid-beta and tau biomarkers become abnormal 
long before symptoms appear, followed by brain atrophy measures and cognitive 
decline. Motivated by this hypothetical model, several data-driven disease 
progression models have been proposed in recent years, which aggregate information 
from multiple biomarkers into a single time frame representing disease progression. 
One such model is the Event-Based Model (EBM) (Fonteijn et al., 2012; Young et 
al., 2014), which models the progression of disease as a sequence of discrete events, 
representing underlying biomarkers switching from a normal to abnormal state. Other 
types of disease progression models (Donohue et al., 2014; Jedynak et al., 2012; Li et 
al., 2017; Lorenzi et al., 2017; Schiratti et al., 2015) have been developed, that build 
continuous trajectories by "stitching" together short-term follow-up data from 
individual subjects. In contrast to the discrete disease stages that are estimated by the 
EBM, these models also compute a continuous measure of disease stage for every 
individual by estimating individual time shifts and progression speeds. 
 
Current image-based disease progression models estimate the evolution of the disease 
using a small set of biomarkers corresponding to pre-defined regions-of-interest 
(ROI). This ROI parcellation is usually coarse, doesn't allow one to find spatially 
dispersed patterns of atrophy. While spatiotemporal longitudinal models have already 
been demonstrated (Derado et al., 2010; Hyun et al., 2016; Lorenzi et al., 2015), these 
models regress against pre-defined sets of covariates such as age or clinical markers. 
This is problematic because, in the case of age, this assumes all subjects have the 
same age of disease onset. Similarly, clinical markers are noisy, biased, suffer from 
floor/ceiling effects and are not sensitive in pre-symptomatic phases. Recently, some 
spatiotemporal models that estimate subject-specific time-shifts have been developed 
(Bilgel et al., 2016; Koval et al., 2017). However, these models generally cannot 
recover dispersed and disconnected pathological patterns, because they assume 
correlation of voxels based on spatial distance, either through a distance function or 
distance from control points. However, spatially dispersed pathological patterns have 
been observed in AD and related dementias and are hypothesized to appear due to 
interactions of pathology and brain networks (Seeley et al., 2009). Therefore, a 
spatiotemporal disease progression model that allows recovery of dispersed atrophy 
patterns present in AD, is not currently available.  
 
In this work, we present DIVE: Data-driven Inference of Vertexwise Evolution. 
DIVE is a novel disease progression model with single vertex resolution that makes 
only weak assumptions on spatial correlation. In contrast to approaches which model 
temporal trajectories for a small set of biomarker measures based on a priori defined 
ROIs, DIVE models temporal trajectories for each vertex on the cortical surface. 
DIVE combines unsupervised learning and disease progression modelling to identify 
clusters of vertices on the cortical surface that show a similar trajectory of brain 
pathology over a particular patient cohort. This formulation enables us to estimate a 
fine-grained spatial distribution of pathology and also provides a novel parcellation of 
the brain based on temporal change.  
 
We first test DIVE on synthetic data and show that the model can recover known 
biomarker trajectories and disease progression scores. We then demonstrate the 
model on data from two cohorts: the Alzheimer's Disease Neuroimaging Initiative 
(ADNI) and the Dementia Research Centre (DRC), UK. We use the model to reveal 
spatiotemporal patterns of pathology to a much finer resolution than previous models 
and demonstrate the ability to assign subjects to stages that predict progression. 
Finally, we validate DIVE in terms of how robust are the estimated pathology 
patterns and how well the disease progression scores correlate with cognitive tests.  
 
2 Method 
 
In this section we describe the mathematical formulation of DIVE (section 2.1), then 
we show how to fit the model using Expectation Maximisation (section 2.2) and we 
describe further implementation details of the algorithm (section 2.3). Afterwards, we 
outline the synthetic data-generation process (section 2.4) for testing the model in the 
presence of ground truth, as well as the pipeline for pre-processing the ADNI and 
DRC datasets (section 2.5). 
 
 
Figure 1. Diagram of the proposed DIVE model. DIVE assumes that biomarkers of 
pathology (e.g. cortical thinning) can be measured at many vertices (i.e. locations) on 
the cortical surface (A), where each vertex has a distinct trajectory of change during 
disease progression (B). The model thus assigns to every cortical vertex one of a 
small set of temporal trajectories describing the change in some image-based 
measurement (e.g. cortical thickness, amyloid PET, DTI fractional anisotropy 
measures) from beginning to end of the disease progression. The estimation process 
simultaneously estimates the set of clusters, the trajectory defining each cluster, and 
the position of each subject along the trajectories, which are defined on a common 
time line. The process iterates assignment of each vertex to clusters (red, green and 
blue in this diagram) (C), estimation of the trajectory in each cluster (D) and 
estimation of the disease progression score (location along trajectory) for  each 
subject (E), all within an expectation-maximisation framework, until convergence.  
 
2.1  The DIVE model 
 
Figure 1 illustrates the DIVE aims and implementation. DIVE input measures are 
vertexwise or voxelwise biomarker measures in the brain (Fig 1A), such as cortical 
thickness or amyloid load. A vertex is a location on the cortical surface at which a 
biomarker of pathology is quantifiable (e.g. cortical thickness). For each vertex on the 
cortical surface (or voxel in the 3D brain volume), we estimate a unique trajectory 
along the disease progression timeline (Fig 1B), while also estimating subject/visit-
specific disease progression scores (i.e. disease stages). We do that by grouping 
vertices with similar biomarker trajectories into clusters (Fig 1C), and we estimate a 
representative trajectory for every cluster (Fig 1D). Each trajectory is a function of 
subject-/visit-specific disease progression scores (DPS) (Fig 1E). The DPS depends 
linearly on the time since baseline visit, but with subject-specific slope and intercept.  
2.1.1 Modelling Subject-specific Time Shifts 
 
The disease progression score sij for subject i at visit j is defined as a linear 
transformation of time since baseline measurement tij (in years): 
 
 
where αi and βi represent the speed of progression and time shift (i.e. disease onset) of 
subject i.  
 
2.1.2 Modelling Biomarker Trajectory for a Single Vertex 
 
DIVE assumes that the biomarker measure at each vertex on the cortical surface 
follows a sigmoidal trajectory f( . ; θ) over the disease progression score s and with 
parameters θ. We choose a parametric sigmoid function because it is a parsimonious 
parametric model that offers better fit compared to linear models, is monotonic, and 
can account for floor and ceiling effects (Caroli and Frisoni, 2010; Sabuncu et al., 
2011). We also assume that vertices are grouped into K clusters and we model a 
unique trajectory for each cluster k ∈  {1, ... , K}, which will be referred to as cluster 
trajectories. The sigmoidal function f(s; θk) for cluster k is defined as:  
 
 
 
 
where s is the disease progression score from Eq. 1 and θk = [ak, bk, ck, dk] are 
parameters controlling the shape of the trajectory – dk and dk+ak represent the lower 
and upper limits of the sigmoidal function, ck represents the inflection point and 
akbk/4 represents the slope at the inflection point. For a given subject i at visit j, the 
value Vl
ij of its biomarker measurement at vertex l is a random variable that has an 
associated discrete latent variable Zl ∈  [1, ... , K] denoting the cluster it was 
generated from. The value of Vl
ij given that it was generated from cluster Zl can be 
modelled as: 
 
 
 
where N(Vl
ij | f(αi tij + βi | θZl), σZl) represents the probability density function (pdf) of 
the normal distribution that models the measurement noise along the sigmoidal 
trajectory of cluster Zl, having variance σZl. Next, we assume the measurements from 
different subjects are independent, while the measurements from the same subject i at 
different visits j are linked using the disease progression score from Eq. 1. Moreover, 
we also assume a uniform prior on cluster membership Zl. This gives the following 
model: 
 
 
 
 
where I = {(i, j)} represents the set of all the subjects i and their corresponding visits 
j. Furthermore, Vl = [Vl
ij | (i,j) ∈  I] is the 1D array of all the values for vertex l across 
every visit of every subject. Vectors α = [α1, … , αS] and β = [β1, … , βS], where S is 
the number of subjects, denote the stacked parameters for the subject shifts. If a 
subject i has multiple visits, these visits share the same parameters αi and βi. Vectors 
θ = [θ1, … , θK] and σ = [σ1, … , σK], with K being the number of clusters, represent 
the stacked parameters for the sigmoidal trajectories and measurement noise specific 
to each cluster. 
 
2.1.3 Modelling Biomarker Trajectories for all Vertices 
 
So far we have a model for only one vertex on the brain surface. We therefore extend 
the formulation to all the vertices by assuming all these vertex measurements are 
spatially independent, giving the complete data likelihood: 
 
 
 
 
where V = [V1, ... , Vl], Z = [Z1, ... , Zl], L being the total number of vertices on the 
cortical surface. The formulation assumes spatial independence between 
measurements in different vertices, but in section 2.1.4 the model is extended to 
capture spatial correlations. We get the final model log likelihood for incomplete data 
by marginalising over the latent variables Z: 
 
Throughout the article, we will use the shorthand zlk = p(Zl = k). 
 
2.1.4 Modelling Spatial Correlation  
 
The version of the model presented so far does not make any assumptions on spatial 
correlation. However, the regional organisation of the cortex suggests we would 
expect spatial correlation of the vertex measurements. More precisely, measures of 
cortical thickness or other modalities are often similar in neighbouring vertices on the 
cortical surface and likely belong to the same cluster. DIVE can be easily extended to 
include mild spatial constraints on the correlation of vertex measurements via a 
Markov Random Field (MRF), which encourages neighbouring vertices to have the 
same corresponding cluster. We hypothesise that incorporating such constraints 
should reduce the effects of noise and produce a more stable clustering. However, 
this does not model correlation between the actual vertex values, but only between 
the latent variables Zl, i.e. the cluster membership of each vertex. The MRF thus has 
the advantage of not requiring the use of huge covariance matrices, which are 
otherwise needed if we want to model correlation of vertex values directly. With the 
MRF, the full-data likelihood function of the model now becomes: 
 
where Ψ(Zl, Zl2) is a clique term representing the likelihood of a neighbouring vertex 
l2 to have similar label with vertex l. The formula for the clique term is: 
 
where λ is a parameter controlling how much to penalise neighbouring vertices that 
belong to distinct clusters, and g and h are positive, monotonic functions over the λ>0 
range. We choose g(λ)=λ and h(λ)=λ2, which results in a concave objective function 
for λ, ensuring that it can later be optimised (see M-step). 
 
Therefore, the model parameters that need to be estimated are M = [α, β, θ, σ, λ] 
where α and β are the subject specific shifting parameters, θ and σ are the cluster 
specific trajectory and noise parameters and λ is the clique parameter denoting the 
penalisation of spatially non-smooth assignments of latent variables Z.  
 
2.2  Fitting the Model using Generalised Expectation-Maximisation 
 
We choose to fit our model using Expectation-Maximisation (EM), because it offers a 
fast convergence given the large number of parameters that need to be estimated and 
the huge dimensionality of relevant datasets (e.g. 1973 subjects x 163,842 vertices in 
ADNI). In the next two sections we outline the E-step and M-step. While both of 
these steps have no closed-form solution, we will solve them using numerical 
optimisation, which only results in an increase in the objective function at each 
iteration. However, the EM algorithm is still guaranteed to converge, and this 
approach is called Generalised EM (Bishop, 2006). 
 Algorithm 1 shows the model fitting procedure using the EM algorithm. The 
procedure first initialises (line 1) some parameters required to start the EM algorithm: 
the subject time shifts α and β and the latent parameters zlk which represent the 
assignment of vertices to clusters. In the M-step, the method updates the trajectories 
of each cluster (lines 4-6), the subjects-specific time shifts (line 9) and the clique 
penalty term λ (line 17). In the E-step, the method computes zlk (line 18) using 
previously defined functions that compute zlk given a fixed λ (line 14). 
 
 
 
 
Algorithm 1. The optimisation procedure for fitting DIVE using the Expectation-
Maximisation algorithm. 
 
 
2.2.1 E-step 
 
In the Expectation step, at iteration u we seek an estimate of p(Z | V, M(u-1)), given the 
current estimates of the parameters M(u-1) =[ θk(u-1), σk(u-1), αi(u-1), βi(u-1), λi(u-1)]. While, 
this does not directly factorise over the vertices l due to the MRF terms, we condition 
the clique terms on the values of Z from the previous iterations. This approximation 
gives the following factorizable likelihood: 
 
The factorised form allows for tractable computation and memory storage of p(Z).  
Let zlk
(u) = p(Zl = k | Vl, M
(u-1),Z(u-1)). After simplifications we reach the following 
update rule: 
 
The full derivation is given in the Supplementary material. In order to enable 
optimisation over λ, a final modification of this step is performed, by considering zlk 
to be functions ζlk(λ) over λ. This results in the update equation from Alg. 1, line 18 
which is based on pre-defined terms on lines 13-14.  
 
2.2.2 M-step 
 
In the Maximisation step we try to estimate the model parameters M = (α, β, θ, σ, λ) 
that maximise EZ|V,M
(u-1)[log p(V,Z|M)]. We cannot simultaneously optimise all 5 sets 
of parameters, so we optimise them independently. In order to get the update rule for 
the trajectory parameters θk corresponding to cluster k we need to maximise the 
expected log likelihood with respect to θk. The key observation here is that if we 
assume fixed α, β and Z, then the trajectory parameters θk for every cluster k are 
conditionally independent, i.e. θk ⊥ θm | (Z, α, β, σ) ∀ (k, m), k ≠ m. This allows us to 
maximise every θk independently using the following equation: 
A similar observation of conditional independence can also be observed for the latent 
variables Z. This allows us to decompose the joint distribution over Z, and after 
expanding the noise model we reach the optimisation problem from Alg. 1, line 4. 
See Supplementary material for full derivation. This does not have a closed-form 
solution, so we use numerical optimisation for finding θk that maximises the equation 
from Alg. 1, line 4. 
 
A similar equation, yet in closed form, is also obtained for σk (Alg. 1, line 6).  After 
estimating θ and σ for every cluster, we use the new values to estimate the subject 
specific parameters α and β. For every subject i, we maximise the expected log 
likelihood with respect to αi, βi independently, and after simplifications we obtain the 
update rule from Alg. 1, line 9, which is again solved using numerical optimisation. 
For the numerical optimisation of θ we used the Nelder-Mead method for its 
robustness, while for α and β we used the second-order Broyden–Fletcher–Goldfarb–
Shanno algorithm due to fast convergence. Finally, we achieved a significant speed-
up in the evaluation of objective functions by computing a zlk-weighted average of 
vertex measurements within each cluster (see Supplementary section 4). This resulted 
in a convergence time of around 6 hours for the larger datasets (ADNI). 
 
For optimising λ, we again try to optimise in the M-step the expected full data 
likelihood under the Z estimates from the previous iteration:  
 
We simplify the above equation by expanding the likelihood model and 
approximating the joint over Z with the product of the marginals zlk over all vertices l. 
This results in the update equation from Alg. 1 line 17 – see supplementary material 
for full derivation. In this final equation we also replaced zlk with a function ζlk(λ) over 
λ, which updates zlk based on the current value of λ being evaluated. This is done to 
increase convergence, as latent variables zlk are highly coupled with the value of λ 
being evaluated. 
 
2.3 Implementation Details 
2.3.1 Parameter initialisation and priors 
 
Before starting the fitting process, we need to initialise α, β and the clustering 
probabilities zlk (Alg. 1, line 1). We set αi and βi to be 1 and 0 respectively for each 
subject, which sets the initial disease progression score to the age of the subject at the 
clinical visit. We initialise zlk using k-means clustering of the vectors Vl. The DPS 
scores have two extra degrees of freedom (scale and shift), which we account for by 
setting informative gamma and Gaussian priors on parameters αi and βi respectively 
(αi ~ Γ(16e4, 16e4), βi ~ N(0, 0.1)), which work well in practice as they result in 
realistic ranges for αi and βi of around [0.3, 3] and [-15,15] respectively.  Such 
informative priors on αi and βi also help deal with singularities in the objective 
functions of αi and βi when the biomarker trajectories are flat. As already explained in 
(Jedynak et al., 2012), the sigmoid parameters θk are not identifiable, so we need to 
apply the following transformation on line 5 of Alg. 1: if bk
(u) < 0 then ak
(u) = – ak(u); 
bk
(u) = – bk(u); dk(u) = dk(u) – ak(u). This ensures model identifiability and is performed at 
every iteration.  
 
2.3.2 Estimating the Optimal Number of Clusters 
The EM procedure needs to specify a-priori the number of clusters to fit on the data. 
We optimise the number of clusters K using Akaike Information Criterion (AIC), 
which we found to better agree with ground truth in simulations than other 
information criteria such as the Bayesian Information Criteria (BIC). The number of 
parameters of the fitted model is 5K+2S+1, where S is the number of subjects. Note 
that zlk are not included as parameters of the model because they are latent variables 
that are marginalised (see Eq. 6). We repeat the fitting procedure for each K from 2 to 
100 clusters and select the K that minimises the AIC. 
 
2.4 Simulation Experiments 
2.4.1 Motivation 
Initial assessment of DIVE performance uses synthetic data, where we know the 
ground truth. The aim is to explore how accurately we can recover ground truth 
parameters as the problem becomes harder in three different scenarios: 
Scenario 1: as the number of clusters increases, evaluate how well DIVE can estimate 
the correct number of clusters using AIC and BIC 
Scenario 2: as the trajectories become more similar, test how well we can recover the 
assignment of vertices to clusters and the DIVE parameters 
Scenario 3: same as Scenario 2, but for decreasing number of subjects 
 
2.4.2 Synthetic Data Generation 
 
We first designed a basic simulation, which the model should be able to fit well since 
the trajectories were designed to be well separated and enough subject data was 
generated along the disease time course. The data in the basic simulation was 
generated as follows:  
1. sample age ai1 and time shift parameters αi, βi for 300 subjects with 4 timepoints 
(each timepoint 1 year apart), with ai1 ~ U(40,80), αi ~ Γ(6.25, 6.25), βi ~ N(0, 10). 
Time since baseline has been obtained for every visit j of subject i as follows: tij = aij 
– ai1 
2. generate three sigmoids with different (slope, centre) parameters: [(-0.1, -15), (-
0.1, 2.5), (-0.1, 20)] (Fig. 2A, red lines). Upper and lower limits have been set to 1 
and 0 respectively. 
3. randomly assign every vertex l ∈ {1, ..., L} where L = 1000, to a cluster a[l] ∈  
{1,2,3} 
4. sample a set of L perturbed trajectories θl from each of the original trajectories, one 
for each vertex (Fig. 2A, gray lines) using covariance matrix Cθ = diag([0, 2bk/15,  
11.6, 0]). 
5. sample subject data for every vertex l from its corresponding perturbed trajectory 
θl with noise standard deviation σl = 1. 
 
From the basic simulation, we generated synthetic data for each of the three scenarios 
by varying one parameter at a time and kept the other parameters constant, having the 
same values as in the basic simulation. We varied the following parameters: 
Scenario 1: number of clusters - 2, 3, 5, 10, 15, 20, 30 and 40. The cluster centres 
were spread evenly across a fixed total DPS range where data was available.  
Scenario 2: distance between trajectory centres (as proportion of total DPS range 
sampled) – 0.33, 0.30, 0.23, 0.17, 0.10, 0.07, 0.03 and 0.02  
Scenario 3: number of subjects - 300, 200, 100, 50, 35, 20, 10 and 5 
 
2.4.3 Model Fitting and Evaluation 
 
Since there was no spatial information in the data generation procedure, we used 
DIVE without the MRF extension. For Scenario 1, we estimated using AIC and BIC 
the optimal number of clusters. For Scenarios 2 and 3, after fitting the parameters of 
DIVE, we calculated the agreement between the final clustering probabilities p(Zl) 
and the true clustering assignments a[l]. This agreement, which we will call the 
clustering agreement, is defined as א = maxτ (1/L)ΣLl=1 p(Zl = τ(a[l])), where τ is any 
permutation of cluster labels. We also computed the error in the DPS estimation (sum 
of squared differences, SSD) and trajectory estimation (SSD between predicted 
trajectory and true trajectory at DPS points of every subject visit).  
 
2.5  Data Acquisition and Pre-processing 
 
Data used in this work were obtained from the Alzheimer's Disease Neuroimaging 
Initiative (ADNI) database (adni.loni.usc.edu) and from the Dementia Research 
Centre, UK. For ADNI, we downloaded all T1 MR images that have undergone 
gradient warping, intensity correction, and scaling for gradient drift. We included 
subjects that had at least 3 scans, to ensure we get a robust estimate of the subject 
specific parameters. This resulted in 138 healthy controls, 235 subjects with mild 
cognitive impairment (MCI) and 81 subjects with Alzheimer's disease.  
 
We also downloaded all AV45 PET images from ADNI that were fully pre-
processed, having the tag 'Co-reg, Avg, Std Img and Vox Siz, Uniform Resolution'. 
This meant that the images were co-registered, averaged across the 6 five-minute 
frames, standardised with respect to the orientation and voxel size and smoothed to 
produce a uniform resolution of 8mm full-width/half-max (FWHM).  
 
The DRC dataset consisted of T1 MRI scans from 31 healthy controls, 32 PCA and 
23 typical AD subjects with at least 3 scans each and an average of 5.26 scans per 
subject. All PCA patients fulfilled the (Tang-Wai et al., 2004) criteria and (Mendez et 
al., 2002) criteria based on clinical review. The typical AD patients all met the 
criteria for probable Alzheimer's disease (Dubois et al., 2010; Dubois et al., 2007).  
 
Given that the ADNI and DRC datasets contained subjects with different modalities 
or diseases, we ran DIVE independently on the following four cohorts (see Table 1 
for demographics):  
1) ADNI MRI: controls, MCI and tAD subjects from ADNI (cortical thickness data) 
2) DRC tAD: tAD subjects and controls from the DRC dataset (cortical thickness 
data) 
3) DRC PCA: PCA subjects and controls from the DRC dataset (cortical thickness 
data) 
4) ADNI PET: AV45 scans from ADNI containing subjects with following 
diagnoses: healthy controls, subjective memory complaints, early MCI, late MCI 
and Alzheimer’s disease. 
 
 
Table 1. Demographics of the three cohorts used in our analysis. ADNI MRI and the 
DRC cohorts were used for the cortical thickness analysis, while ADNI PET was 
used for the PET AV45 analysis. MCI – mild cognitive impairment, SMC - 
subjective memory complaints, EMCI – early MCI, LMCI – late MCI. 
 
2.5.1 Image Pre-processing 
2.5.1.1 MR Images 
 
On both datasets, in order to extract reliable cortical thickness measures, we ran the 
Freesurfer longitudinal pipeline (Reuter et al., 2012), which first registers the MR 
scans to an unbiased within-subject template space using inverse-consistent 
registration. The longitudinally registered images were then registered to the average 
Freesurfer template. No further smoothing was performed on these images (FWHM 
level of zero mm). From these template-registered volumetric images, cortical 
thickness measurements were computed at each vertex (i.e. point) on an average 2D 
cortical surface manifold. For each vertex we averaged the thickness levels from both 
hemispheres. Finally, we standardised the data from each vertex with respect to the 
values of that vertex in the control population. Each of the final images had a 
resolution of 163,842 vertices on the cortical surface.  
 
2.5.1.2 PET AV45 Images 
 
We computed amyloid SUVR levels using the PetSurfer pipeline (Greve et al., 2016; 
Greve et al., 2014), which is available with Freesurfer version 6. The PetSurfer 
pipeline first registers the PET image with the corresponding MRI scan, then applies 
Partial Volume Correction, and finally resamples the voxelwise SUVR values onto 
the cortical surface. While the final images also had a resolution of 163,842 vertices, 
the PET data we obtained from ADNI was inherently more smooth than the MRI 
cortical thickness data (8mm FWHM).  
 
2.5.2 The MRF Neighbourhood Graph 
 
We estimated the MRF neighbourhood graph based on a Freesurfer triangular mesh 
for the fsaverage template. Each vertex was a triangle on the brain surface estimated 
with Freesurfer, and we connected the vertices if the corresponding triangles had a 
shared edge. For the MRF neighbourhood graph, we used a 3rd degree neighbourhood 
structure, meaning that two vertices were considered neighbours if the shortest path 
between them was not higher than 3.  
 
3 Results 
We first present results on synthetic data (section 3.1), then on ADNI and DRC 
datasets (section 3.2), followed by model evaluation (section 3.3) using cross-
validation and correlation with cognitive markers. 
3.1 Results on synthetic data 
 
In the basic simulation, we obtained a clustering agreement א of 0.97, which suggests 
that almost all vertices were assigned to the correct cluster. Figure 2A shows the 
original trajectories and the recovered trajectories using our model, plotted against 
the disease progression score on the x-axis and the vertex value on the y-axis. In Fig. 
2B we plotted the recovered DPS of each subject along with the true DPS. The results 
for the three scenarios are shown in Figs. 2C-E. In Fig 2C, we show for Scenario 1 
the estimated number of clusters against the true number of clusters using both AIC 
and BIC criteria. In Figs 2D-E we show the distributions for א in Scenarios 2 and 3 as 
the problem becomes harder in each successive step.  
 
 
Figure 2. (A-B) Results for the basic simulation, where trajectories are relatively well 
separated. (A) Reconstructed temporal trajectories (blue) plotted against the true 
trajectories (red). The x-axis shows the disease progression score (DPS), while the y-
axis shows the biomarker values of the vertices. (B) Estimated subject-specific DPS 
scores compared to the true scores. (C-E) Simulation results for the three scenarios: 
(C) increasing number of clusters, (D) trajectories becoming similar and (E) 
decreasing number of subjects. On the x-axis we show the variable that was changing 
within the scenario (e.g. number of clusters), while on the y-axis we show the 
agreement measure א, representing the percentage of vertices that were assigned to 
the correct cluster. 
 
The results show that, in a simple experiment where the trajectories are well 
separated, DIVE can very accurately estimate which clusters generated each vertex. 
Moreover, the recovered trajectories and DPS scores are close to the true values. The 
results of Scenario 1 also suggest that both AIC and BIC are effective at estimating 
the correct number of known clusters, with AIC having slightly better performance 
than BIC for larger numbers of clusters. On the other hand, the results of the stress 
test scenarios 2 and 3 show that performance measure א drops when the trajectories 
become very similar with each other or when the number of subjects decreases. This 
happens because small differences in trajectories are hard to detect in the presence of 
measurement noise, while a small number of subjects doesn’t provide enough data to 
accurately estimate the parameters. Similar decreases in performance for scenarios 2 
and 3 are observed also for other measures, such as the error in recovered trajectories 
or DPS scores (Supplementary Fig 1). 
 
3.2 Results on ADNI and DRC Datasets 
3.2.1 Initial Hypotheses 
 
Using ADNI and DRC datasets, we aim to recover the spatial distribution of cortical 
atrophy and amyloid pathology, as well as the rate and timing of these pathological 
processes. In particular, we hypothesize that these spatial patterns of pathology and 
their evolution will be:  
1. similar on two independent typical AD datasets: ADNI and DRC 
2. different on distinct diseases: tAD vs PCA  
3. different in distinct modalities: cortical thickness from MRI vs amyloid load from 
AV45 PET. 
 
 
3.2.2 Results 
 
The optimal number of clusters, as estimated with AIC, was three for the ADNI MRI 
dataset, three for the DRC tAD dataset, five for the DRC PCA dataset and eighteen 
for the ADNI PET dataset. Fig. 3A-left shows the results from the ADNI MRI 
dataset, where in the left image we coloured the vertices on the cortical surface 
according to the cluster they most likely belong to. We assigned a colour for each 
cluster (both the brain figures on the left and the trajectory figures on the right) 
according to the extent of pathology of its corresponding trajectory at a DPS score of 
1. The cluster colours range from red (severe pathology) to blue (moderate 
pathology). In Fig. 3A-right, we show the resulting cluster trajectories with samples 
from the posterior distribution of each θk. Similar results are shown for the other three 
datasets: the DRC tAD dataset (Fig. 3B), DRC PCA dataset (Fig. 3C) and the ADNI 
PET dataset (Fig. 3D). 
 Figure 3. (left column) DIVE estimated clusters (left column) and corresponding 
disease progression trajectories (right column) on four datasets: (A) ADNI MRI (B) 
DRC tAD (C) DRC PCA and (D) ADNI PET. We coloured each cluster according to 
the extent of pathology (cortical thickness or amyloid uptake) at DPS=1.  
 
We notice that in tAD subjects using the ADNI datasets (Fig. 3A), there is more 
severe cortical thinning mainly in the inferior temporal lobe (red cluster), with 
disperse atrophy also in parietal and frontal regions (green cluster), with relative 
sparing of the inferior frontal and occipital lobes. In tAD subjects from the DRC 
dataset, we see a relatively similar pattern, however with more pronounced atrophy in 
the supramarginal cortex (red cluster) compared to ADNI. The spatial distribution of 
cortical thinning found with DIVE resembles results from previous longitudinal 
studies such as (Dickerson et al., 2008; Singh et al., 2006). However, in contrast to 
these approaches, our model gives insight into the timing and rate of atrophy and is 
also able to stage subjects across the disease time course. We also find that the cluster 
trajectories in the DRC tAD dataset have similar dynamics to the ADNI MRI dataset, 
although they show a clearer separation between each other. 
 
In the PCA subjects (Fig. 3C), we find that atrophy is mainly focused on the posterior 
part of the brain, mostly the posterior parietal and supramarginal areas, with limited 
spread in the motor cortex, anterior temporal and frontal areas. There is a clear 
separation of atrophy extent between the anterior and posterior part of the brain, with 
the boundary running along the motor cortex. This posterior-focused pattern of 
atrophy is different from the one found in the tAD datasets, and agrees with previous 
findings in the literature (Crutch et al., 2012; Lehmann et al., 2011).  
 
In ADNI PET (Fig. 3D) we see that the regions with the highest amyloid uptake are 
more spatially continuous, comprising the precuneus and anterior frontal areas. On 
the other hand, the anterior-superior temporal gyrus shows the least uptake of 
amyloid. This result closely matches the result by (Bilgel et al., 2016), which used a 
completely different dataset and modelling technique. The “layers of clusters” 
starting from the precuneus and frontal lobes, which range from severe to less severe 
atrophy, suggest a continuum of variation in vertex trajectories in the case of the PET 
dataset (Fig 3D-right). These trajectories all start with a low amyloid SUVR, between 
0 and 0.25, but in late stages the trajectories for some clusters such as cluster 0 can 
reach an SUVR of 1.5. The reason for seeing this continuum might be because the 
PET images have a much lower resolution than MR images and were smoothed by 
ADNI during the pre-processing steps. 
 
3.3 Model Evaluation 
3.3.1 Motivation 
 
We further tested the robustness and validity of the model as follows:  
1. Robustness in parameter estimation: test whether similar spatial clustering is 
estimated for different subsets of the data 
2. Clinical validity of DPS scores: test whether the subject disease progression scores, 
based purely on MRI or PET data, correlate with cognitive tests such as Clinical 
Dementia Rating Scale - Sum of Boxes (CDRSOB), Alzheimer's Disease Assessment 
Scale - Cognitive (ADAS-COG), Mini-Mental State Examination (MMSE) and Rey 
Auditory and Verbal Learning Test (RAVLT). 
3. Prediction accuracy: given initial baseline scans from different subjects, test how 
accurately DIVE can predict the biomarker evolution of those patients over time. 
4. Comparison with other models: we compared the performance of DIVE with a 
region-of-interest based method (Jedynak et al., 2012) and a no-staging method that 
doesn’t estimate subject time shifts. See Supplementary Section 2 for precise 
specifications. 
 3.3.2 Evaluation Procedure 
 
For all scenarios, we ran 10-fold cross-validation (CV) on the ADNI MRI dataset. At 
each fold we fit the model using 3 clusters, since this was the optimal number of 
clusters found previously on the entire dataset. The trained model was then used to 
estimate the DPS of the test subjects.  
 
 
 
Figure 4. (top) Clusters estimated from 10-fold cross-validation training sets on the 
ADNI MRI dataset. (bottom) Estimated trajectories for each fold.  
 
3.3.3 Evaluation Results 
 
Fig. 4 shows the brain clusters and corresponding trajectories, estimated for all the 
cross-validation folds after fitting the model on the training data. The clusters have 
been coloured using a similar colour scheme as in Fig. 3. In Fig 5 we show scatter 
plots of the DPS scores with clinical measures such as CDRSOB, ADAS-COG, 
MMSE and RAVLT.  
 Fig 5. Scatter plots of the DPS scores estimated from the ADNI MRI dataset, plotted 
against four cognitive tests: CDRSOB, ADAS-COG, MMSE and RAVLT. For each 
cognitive test we also report the correlation coefficient and p-value. The disease 
progression scores, computed only based on MRI cortical thickness data, correlate 
with these cognitive measures, suggesting that the DPS scores are clinically 
meaningful.  
 
 
Table 2. Performance evaluation of DIVE and two other models on the ADNI MRI 
dataset using 10-fold cross-validation. In the middle four columns, we show the 
correlation of the DPS scores with respect to several cognitive tests: CDRSOB, 
ADAS-Cog13, MMSE and RAVLT. The last column shows the prediction error 
(RMSE) of cortical thickness values from follow-up scans. (*) Statistically significant 
differences between the model and DIVE, Bonferroni corrected for multiple 
comparisons. 
 
The results in Fig. 4 demonstrate that DIVE is robust in cross-validation, as the 
estimated clusters and trajectory parameters are all similar across folds. The average 
Dice score overlap across the 10-folds range were 0.77, 0.76 and 0.90 for clusters 0, 1 
and 2 respectively. The DIVE-derived DPS scores, which were estimated purely 
based on MRI data, are also clinically relevant as they correlate with cognitive tests 
(Fig 5).  
 
The performance of DIVE in terms of subject staging and biomarker prediction also 
compares favourably with simpler no-staging and ROI-based models (Table 2). 
Results show that DIVE has comparable performance to the ROI-based model, both 
in terms of subject staging and cortical thickness prediction. The fact that DIVE has 
similar performance to a simpler model which has less parameters is evidence that the 
estimated patterns are meaningful. Moreover, DIVE offers qualitative insight into the 
fine-grained spatial patterns of pathology and their temporal progression. 
Furthermore, the No-staging model performs significantly worse than DIVE, both in 
terms of subject staging and for biomarker prediction. This suggests that, when 
modelling progression of AD, it is important to account for the fact that patients are 
at different stages along the disease time-course. 
 
4 Discussion 
4.1.1 Summary and Key Findings 
We presented DIVE, a spatiotemporal model of disease progression that clusters 
vertex- or voxel-wise measures of pathology in the brain based on similar temporal 
dynamics. The model highlights, for the first time, groups of cortical vertices that 
exhibit a similar temporal trajectory over the population. The model also estimates 
the temporal shift and progression speed for every subject. We applied the model on 
cortical thickness vertex-wise data from three MRI datasets (ADNI, DRC tAD and 
DRC PCA), as well as an amyloid PET dataset (ADNI). Our model found 
qualitatively similar patterns of cortical thinning in tAD subjects using the two 
independent datasets (ADNI and DRC). Moreover, it also found different patterns of 
pathology dynamics on two distinct diseases (tAD and PCA) and on different types of 
data (PET and MRI-derived cortical thickness). Finally, DIVE also provides a new 
way to parcellate the brain that is specific to the temporal trajectory of a particular 
disease. 
 
4.1.2 Limitations and future work 
 
DIVE has some limitations that can be addressed. First, we assumed that cluster 
trajectories follow sigmoidal shapes, which is not the case for many types of 
biomarkers in ADNI which do not plateau in later stages. The assumption of 
sigmoidal trajectories can be avoided using non-parametric curves such as Gaussian 
Processes (Lorenzi et al., 2017), which would be straightforward to incorporate into 
the DIVE framework. Another limitation of the model is that it assumes all subjects 
follow the same disease progression pattern, which might not be the case in 
heterogeneous datasets such as ADNI or DRC. This can be a concern, as there might 
be a pattern of pathology that occurs in a small set of subjects. However, DIVE can 
be extended to account for heterogeneity in the datasets by modelling different 
progression dynamics for distinct subgroups, using unsupervised learning methods 
like the SuStaIn model by (Young et al., 2018). While SuStaIn, just like DIVE, 
estimates clusters and trajectories within the dataset, the clusters in SuStaIn are made 
of subjects with similar disease progression, while the clusters in DIVE are made of 
vertices with similar progression. Future work could combine clustering along both 
subjects and vertices simultaneously to estimate disease subtypes with distinct 
spatiotemporal dynamics at the vertexwise level. 
 
There are several potential future applications of DIVE. One of the advantages of 
DIVE is that it can be used to study the link between disconnected patterns of brain 
pathology and connectomes extracted from diffusion tractography or functional MRI 
(fMRI). Such an analysis would enable further understanding of the exact underlying 
mechanisms by which the brain is affected by the disease. Our model, which can 
estimate fine-grained spatial patterns of pathology, is more suitable than standard 
ROI-based methods for studying the link between pathology and these structural or 
functional connectomes, because white matter or functional connections have a fine-
grained and spatially-varying distribution of endpoints on the cortex. 
 
Apart from studying the link with brain connectomes, there are other potential 
applications for DIVE. The model can be applied to study other types of vertexwise 
or voxelwise data, such as FDG PET, tau PET, DTI or Jacobian compression maps 
from MRI. Moreover, the model can also be extended to cluster points on the brain 
surface according to a more complex disease signature, that can be made of two or 
more biomarkers. For example, using our cortical thickness and amyloid PET 
datasets from ADNI, we could have clustered points on the brain based on both 
modalities simultaneously. Such complex disease signatures can offer important 
insights into the relationships between different modalities and underlying disease 
mechanisms. 
 
DIVE is a spatiotemporal model that can be used for accurately predicting and 
staging patients across the progression timeline of neurodegenerative diseases. The 
spatial patterns of pathology can also be used to test mechanistic hypotheses which 
consider AD as a network vulnerability disorder. All these avenues can help towards 
disease understanding, patient prognosis, as well as clinical-trials for assessing 
efficacy of a putative treatment for slowing down cognitive decline. 
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Supplementary Material
1 Simulations - Error in Estimated Trajectories and DPS
A B
C D
Figure 1: Error in DPS scores (A) and trajectory estimation (B) for Scenario 2 in simulation experiments.
(C-D) The same error scores for Scenario 3. We notice that as the problem becomes more difficult, the errors in
the DIVE estimated parameters increase. Errors were measured as sum of squared differences (SSD) between
the true parameters and estimated parameters. For the trajectories, the SSD was calculated only based on the
sigmoid centres, due to different scaling of the other sigmoidal parameters.
2 Comparison between DIVE and other models
2.1 Motivation
We were also interested to compare the performance of DIVE with other disease progression models. In
particular, we were interested to test whether:
• Modelling dynamic clusters on the brain surface improves subject staging and biomarker prediction
• Modelling subject-specific stages with a linear transformation (the αi and βi terms) improves biomarker
prediction
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2.2 Experiment design
We compared the performance of our model to two simplified models:
• ROI-based model: groups vertices according to an a-priori defined ROI atlas. This model is equivalent
to the model by Jedynak et al., Neuroimage, 2012 and is a special case of our model, where the latent
variables zlk are fixed instead of being marginalised as in equation 6.
• No-staging model: This is a model that doesn’t perform any time-shift of patients along the disease
progression timeline. It fixes αi = 1, βi = 0 for every subject, which means that the disease progression
score of every subject is age.
We performed this comparison using 10-fold cross-validation. For each subject in the test set, we computed
their DPS score and correlated all the DPS values with the same four cognitive tests used previously. We also
tested how well the models can predict the future vertex-wise measurements as follows: for every subject i in
the test set, we used their first two scans to estimate αi = 1, βi = 0 and then used the rest of the scans to
compute the prediction error. For one vertex location on the cortical surface, the prediction error was computed
as the root mean squared error (RMSE) between its predicted measure and the actual measure. This was then
averaged across all subjects and visits.
2.3 Results
Table 1 shows the results of the model comparison, on ADNI MRI dataset. Each row represents one model
tested, while each column represents a different performance measure: correlations with four different cognitive
tests and accuracy in the prediction of future vertexwise measurements. In each entry, we give the mean and
standard deviation of the correlation coefficients or RMSE across the 10 cross-validation folds.
Model CDRSOB (ρ) ADAS13 (ρ) MMSE (ρ) RAVLT (ρ) Prediction (RMSE)
DIVE 0.37 +/- 0.09 0.37 +/- 0.10 0.36 +/- 0.11 0.32 +/- 0.12 1.021 +/- 0.008
ROI-based model 0.36 +/- 0.10 0.35 +/- 0.11 0.34 +/- 0.13 0.30 +/- 0.13 1.019 +/- 0.010
No-staging model *0.09 +/- 0.06 *0.03 +/- 0.09 *0.05 +/- 0.06 *0.02 +/- 0.06 *1.062 +/- 0.024
Table 1: Comparison of our model with two more simplistic models on the ADNI MRI dataset. For each of the
three models, we show the correlation of the disease progression scores (DPS) with respect to several cognitive
tests: CDRSOB, ADAS13, MMSE and RAVLT. The correlation numbers represent the mean correlation across
the 10 cross-validation folds.
3 Validation of subject parameters against APOE
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Figure 2: Subject-specific parameters (left: time shift parameters β, middle: progression speed α and right:
DPS scores at baseline visit) for APOE4-positive and negative individuals. APOE4 positive subjects have
significantly higher time-shifts, progression speeds and overall DPS scores than APOE4-negative individuals.
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4 Derivation of the Generalised EM algorithm
We seek to calculateM (u) = arg maxM EZ|V,M(u−1) [log p(V,Z|M)]+log p(M) whereM (u) = (α(u), β(u), θ(u), σ(u), λ(u))
are the set of model parameters at iteration u of the EM algorithm, and Z = (Z1, . . . , ZL) is the set of discrete
latent variables, where Zl represents the cluster that voxel l was assigned to, so Zl ∈ 1, . . . ,K. While Zl (with
capital letter) is a random variable, we will also use the notation zl (small letter) to represent the value that
the random variable Zl was instantiated to. Finally, p(M
(u)) is a prior on these parameters that is chosen by
the user. Expanding the expected value, we get:
M (u) = arg max
M
K∑
z1,...,zL
p(Z = (z1, ..., zL)|V,M (u−1)) [log p(V,Z|M)] + log p(M) (1)
The E-step involves computing p
(
Z = (z1, ..., zL)|V,M (u−1)
)
, while the M-step comprises of solving the
above equation.
4.1 E-step
In this step we need to estimate p(Z|V,M (u−1)). For notational simplificy we will drop the (u− 1) superscript
from M
p(Z|V,M) = 1
C
p(V,Z|M) =
L∏
l
 ∏
(i,j)∈I
N(V ijl |f(αitij + βi|θZl), σZl)
∏
l2∈Nl
Ψ(Zl, Zl2)
 (2)
where Nl is the set of neighbours of vertex l. However, this doesn’t directly factorise over the vertices l due to
the MRF terms Ψ(Zl, Zl2). It is however necessary to find a form that factorises over the vertices, otherwise we
won’t be able to represent in memory the joint distribution over all Z variables. If we make the approximation
p(Z|V,M) ≈ ∏Ll p(Vl|Zl,M) then we loose out all the MRF terms and the model won’t account for spatial
correlation. We instead do a first-degree approximation by conditioning on the values of Z
(u−1)
Nl
, the labels of
nearby vertices from the previous iteration. The approximation is thus:
p(Z|V,M) ≈
L∏
l
E
Z
(u−1)
Nl
|Vl,M
[
p(Zl|Vl,M,Z(u−1)Nl )
]
(3)
This form allows us to factorise over all the vertices to get p(Zl|Vl,M):
p(Zl|Vl,M) ≈ 1
C
∑
Z
(u−1)
Nl
p(Vl|Zl,M)p(Zl|Z(u−1)Nl )p(Z
(u−1)
Nl
|Vl,M) (4)
where C is a normalistion constant that can be dropped. We can now further factorise p(Zl|Z(u−1)Nl ) ≈∏
m∈{1,...,Nl} p(Zl|M,Z
(u−1)
Nl(m)
= zNl(m)) and apply a similar factorisation to the prior p(Z
(u−1)
Nl
|Vl,M), resulting
in:
p(Zl|Vl,M) ≈ 1
C
p(Vl|Zl,M)
∑
zNl(1),..,zNl(|Nl|)
∏
m∈{1,...,Nl}
p(Zl|Z(u−1)Nl(m) = zNl(m))p(Z
(u−1)
Nl(m)
= zNl(m)|Vl,M) (5)
Factorising the summation over zNl ’s we get:
p(Zl|Vl,M) = p(Vl|Zl,M)
∏
l2∈Nl
∑
zl2
p(Zl|Z(u−1)l2 = zl2)p(Z
(u−1)
l2
= zl2 |Vl,M) (6)
Replacing zl2 with k2 we get:
p(Zl|Vl,M) = p(Vl|Zl,M)
∏
l2∈Nl
∑
k2
p(Zl|Z(u−1)l2 = k2)p(Z
(u−1)
l2
= k2|Vl,M) (7)
We shall also denote zlk = p(Zl|Vl,M). Further simplifications result in:
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z
(u)
lk ∝
∏
i,j∈I
N(V ijl |f(αitij + βi; θk), σk)
 ∏
l2∈Nl
K∑
k2=1
z
(u−1)
l2k2
Ψ(Zl = k, Zl2 = k2)
 (8)
log z
(u)
lk ∝
∑
i,j∈I
− log (2piσ
2
k)
2
− 1
2σ2k
(V ijl − f(αitij + βi; θk))2
+[ ∑
l2∈Nl
log
K∑
k2=1
z
(u−1)
l2k2
(δk2k exp(λ) + (1− δk2k) exp(−λ2))
]
(9)
We further define the data-fit term Dlk as follows:
Dlk = − log (2piσ
2
k)|I|
2
−
∑
i,j∈I
1
2σ2k
(V ijl − f(αitij + βi; θk))2 (10)
This results in:
log z
(u)
lk ∝ Dlk +
[ ∑
l2∈Nl
log
K∑
k2=1
z
(u−1)
l2k2
(δk2k (exp(λ)− exp(−λ2)) + exp(−λ2))
]
(11)
Finally, we simplify the sum over k2 to get the update equation for zlk:
log z
(u)
lk ∝ Dlk +
∑
l2∈Nl
log
[
exp(−λ2) + z(u−1)l2k (exp(λ)− exp(−λ2))
] (12)
In practice, we cannot naively compute the exponential term zlk = exp(log(zlk)) due to precision loss. How-
ever, we go around this by recomputing the exponentiation and normalisation of zlk simultaneously. Denoting
x(k) = log zlk, for k ∈ [1 . . .K], we get:
zlk =
ex(k)
ex(1) + ex(2) + · · ·+ ex(K) =
1
ex(1)−x(k) + ex(2)−x(k) + · · ·+ ex(K)−x(k) (13)
4.2 M-step
The M-step itself does not have a closed-form analytical solution. We choose to solve it by successive refinements
of the cluster trajectory parameters and the subject time shifts.
4.2.1 Optimising trajectory parameters
Trajectory shape - θ
Taking equation 1 and fixing the subject time-shifts α, β and measurement noise σ, we can find its maximum
with respect to θ only. More precisely, we want:
θ = arg max
θ
K∑
z1,...,zL
p(Z = (z1, ..., zL)|V,M (u−1)) [log p(V,Z|M)] + log p(θ) (14)
We observe that for each cluster the individual θk’s are conditionally independent, i.e. θk ⊥⊥ θm|{Z,α, β, σ}
∀k,m. We also assume that the prior factorizes for each θk: log p(θ) =
∏K
k log p(θk). This allows us to optimise
each θk independently:
θk = arg max
θk
K∑
z1,...,zL
p(Z = (z1, ..., zL)|V,M (u−1)) [log p(V,Z|M)] + log p(θk) (15)
Replacing the full data log-likelihood, we get:
θk = arg max
θk
K∑
z1,...,zL
p(Z = (z1, ..., zL)|V,M (u−1)) log
 L∏
l=1
∏
(i,j)∈I
N(V ijl |f(αitij + βi; θzl), σzl)
+ log p(θk) (16)
28
Note that we didn’t include the MRF clique terms, since they are not a function of θk. We propagate the
logarithm inside the products:
θk = arg max
θk
K∑
z1,...,zL
p(Z = (z1, ..., zL)|V,M (u−1))
L∑
l=1
∑
(i,j)∈I
log N(V ijl |f(αitij + βi; θzl), σzl) + log p(θk) (17)
We next assume that Zl, the hidden cluster assignment for vertex l, is conditionally independent of the
other vertex assignments Zm, ∀m 6= l (See E-step approximation from Eq. 3). This independence assumption
induces the following factorization: p(Z = (z1, ..., zL)|V,M (u−1)) =
∏L
l p(Zl = zl|V,M (u−1)). Propagating this
product inside the sum over the vertices, we get:
θk = arg max
θk
L∑
l=1
K∑
zl=1
p(Zl = zl|V,M (u−1))
∑
(i,j)∈I
log N(V ijl |f(αitij + βi; θzl), σzl) + log p(θk) (18)
The terms which don’t contain θk dissapear:
θk = arg max
θk
L∑
l=1
p(Zl = k|V,M (u−1))
∑
(i,j)∈I
log N(V ijl |f(αitij + βi; θk), σk) + log p(θk) (19)
We further expand the gaussian noise model:
θk = arg max
θk
L∑
l=1
p(Zl = k|V,M (u−1))
∑
(i,j)∈I
[
log (2piσk)
−1/2 − 1
2σ2k
(V ijl − f(αitij + βi; θk))2
]
+ log p(θk) (20)
Constants dissapear due to the arg max and we get the final update equation for θk:
θk = arg max
θk
L∑
l=1
p(Zl = k|V,M (u−1))
∑
(i,j)∈I
[
− 1
2σ2k
(V ijl − f(αitij + βi; θk))2
]
+ log p(θk) (21)
Measurement noise - σ
We first assume a uniform prior on the σ parameters to simplify derivations. Using a similar approach as
with θ, after propagating the product inside the logarithm and removing the terms which don’t contain σk, we
get:
σk = arg max
σk
L∑
l=1
p(Zl = k|V,M (u−1))
∑
(i,j)∈I
log N(V ijl |f(αitij + βi; θk), σk) (22)
Note that, just as for θ above, the MRF clique terms were not included because they are not a function of
σk. Expanding the noise model we get:
σk = arg max
σk
L∑
l=1
p(Zl = k|V,M (u−1))
∑
(i,j)∈I
[
log (2piσ2k)
−1/2 − 1
2σ2k
(V ijl − f(αitij + βi; θk))2
]
(23)
The maximum of a function l(σk) can be computed by taking the derivative of the function l and setting
it to zero. This is under the assumption that l is differentiable, which it is but we won’t prove it here. This
gives:
δl(σk|.)
δσk
=
L∑
l=1
p(Zl = k|V,M (u−1))
∑
(i,j)∈I
δ
δσk
[
log (2piσ2k)
−1/2 − 1
2σ2k
(V ijl − f(αitij + βi; θk))2
]
(24)
Propagating the differential operator further inside the sums we get:
δl(σk|.)
δσk
=
L∑
l=1
p(Zl = k|V,M (u−1))
∑
(i,j)∈I
[
− δ
δσk
log σ2k
2
− δ
δσk
1
2σ2k
(V ijl − f(αitij + βi; θk))2
]
(25)
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We next perform several small manipulations to reach a more suitable form of the derivative and then set
it to be equal to zero:
δl(σk|.)
δσk
=
L∑
l=1
p(Zl = k|V,M (u−1))
∑
(i,j)∈I
[
− 1
σk
− −2
2σ3k
(V ijl − f(αitij + βi; θk))2
]
(26)
δl(σk|.)
δσk
=
L∑
l=1
p(Zl = k|V,M (u−1))
∑
(i,j)∈I
[
−σ
2
k
σ3k
+
1
σ3k
(V ijl − f(αitij + βi; θk))2
]
(27)
δl(σk|.)
δσk
=
L∑
l=1
p(Zl = k|V,M (u−1))
∑
(i,j)∈I
[
−σ2k + (V ijl − f(αitij + βi; θk))2
]
= 0 (28)
Finally, we solve for σk and get its update equation:
σ2k =
1
|I|
L∑
l=1
p(Zl = k|V,M (u−1))
∑
(i,j)∈I
(V ijl − f(αitij + βi; θk))2 (29)
4.2.2 Estimating subject time shifts - α, β
For estimating α, β, we adopt a similar strategy as in the case of θ, up to Eq. 18. This gives us the following
problem:
αi, βi = arg max
αi,βi
L∑
l=1
K∑
k=1
p(Zl = k|V,M (u−1))
∑
(i′,j)∈I
log N(V i
′j
l |f(αi′ti′j + βi′ ; θk), σk) + log p(αi, βi) (30)
The terms αi′ , βi′ for other subjects i
′ 6= i dissappear:
αi, βi = arg max
αi,βi
L∑
l=1
K∑
k=1
p(Zl = k|V,M (u−1))
∑
j∈Ii
log N(V ijl |f(αitij + βi; θk), σk) + log p(αi, βi) (31)
Expanding the gaussian noise model we get:
αi, βi = arg max
αi,βi
L∑
l=1
K∑
k=1
p(Zl = k|V,M (u−1))
∑
j∈Ii
[
log (2piσ2k)
−1/2 − 1
2σ2k
(V ijl − f(αitij + βi; θk))2
]
+log p(αi, βi)
(32)
After removing constant terms we end up with the final update equation for αi, βi:
αi, βi = arg min
αi,βi
 L∑
l=1
K∑
k=1
p(Zl = k|V,M (u−1)) 1
2σ2k
∑
j∈Ii
(V ijl − f(αitij + βi; θk))2
− log p(αi, βi) (33)
4.2.3 Estimating MRF clique term - λ
We optimise λ using the following formula:
λ(u) = arg max
λ
Ep(Z|V,M(u−1),λ,Z(u−1))[log p(V,Z|M (u−1))]
Note that p(Z|V,M (u−1), λ, Z(u−1)) is a function of λ, so for each lambda we estimate zlk through approxi-
mate inference. We do this because otherwise the optimisation of λ will only take into account the clique terms
and completely exclude the data terms. We further simplify the objective function for lambda as follows:
λ(u) = arg max
λ
K∑
z1,...,zL
p(Z = (z1, ..., zL)|V,M (u−1), λ, Z(u−1)) log
 L∏
l=1
∏
(i,j)∈I
N(V ijl |f(αitij + βi; θzl), σzl)
L∏
l=1
∏
l2∈Nl
Ψ(zl, zl2)

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We take the logarithm:
λ(u) = arg max
λ
K∑
z1,...,zL
p(Z = (z1, ..., zL)|V,M (u−1), λ, Z(u−1))
 L∑
l=1
∑
(i,j)∈I
log N(V ijl |..) +
L∑
l=1
∑
l2∈Nl
log Ψ(zl, zl2)

Let us denote zlk = p(Zl = k|V,M (u−1), λ, Z(u−1)). Assuming independence between the latent variables
Zl we get:
λ = arg max
λ
L∑
l=1
K∑
k=1
zlk
 ∑
(i,j)∈I
log N(V ijl |..)
 + L∑
l=1
K∑
k=1
zlk
∑
l2∈Nl
K∑
k2=1
zl2k log Ψ(Zl = k, Zl2 = k2) (34)
However, we now want to make zlk a function of λ as previously mentioned, so zlk = ζlk(λ), for some
function ζlk. More precisely, using the E-step update from Eq. 12 we define for each vertex l and cluster k a
function ζlk(λ) as follows:
ζlk(λ) = exp
Dlk + ∑
l2∈Nl
log
[
exp(−λ2) + z(u−1)l2k (exp(λ)− exp(−λ2))
]
where Dlk is as defined in Eq 10. We then replace zlk with ζlk(λ) and introduce the chosen MRF clique
model to get:
λ(u) = arg max
λ
L∑
l=1
K∑
k=1
ζlk(λ)Dlk +
L∑
l=1
K∑
k
∑
l2∈Nl
K∑
k2=1
ζlk(λ)ζl2k(λ)
[
δkk2λ+ (1− δkk2)(−λ2)
]
We separate the cliques that have matching clusters to the ones that don’t:
λ(u) = arg max
λ
L∑
l=1
K∑
k=1
ζlk(λ)Dlk +
L∑
l=1
∑
l2∈Nl
K∑
k
ζlk(λ)ζl2k(λ) λ+ ∑
k26=k
ζlk(λ)ζl2k(λ)(−λ2)

We also factorise the clique terms:
λ(u) = arg max
λ
L∑
l=1
K∑
k=1
ζlk(λ)Dlk + λ
L∑
l=1
∑
l2∈Nl
K∑
k
ζlk(λ)ζl2k(λ) + (−λ2)
L∑
l=1
∑
l2∈Nl
K∑
k
ζlk(λ)(1− ζl2k(λ))
Finally, we simplify to get the objective function for λ.
λ(u) = arg max
λ
L∑
l=1
K∑
k=1
ζlk(λ)
Dlk + λ ∑
l2∈Nl
ζl2k(λ) − λ2
∑
l2∈Nl
(1− ζl2k(λ))
 (35)
For implementation speed-up, data-fit terms Dlk can be pre-computed.
5 Fast DIVE Implementation - Proof of Equivalence
Fitting DIVE can be computationally prohibitive, especially given that the number of vertices/voxels can be
very high, e.g. more than 160,000 in our datasets. We derived a fast implementtion of DIVE, which is based
on the idea that for each subject we compute a weighted mean of the vertices within a particular cluster,
and then compare that mean with the corresponding trajectory value. This is in contrast with comparing the
value at each vertex with the corresponding trajectory of its cluster. In the next few sections, we will present
the mathematical formulation of the fast implementation for parameters [θ, α, β]. Parameter σ already has a
closed-form update, while parameter λ has a more complex update procedure for which this fast implementation
doesn’t work. For each parameter, we will also provide proofs of equivalence.
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5.1 Trajectory parameters - θ
5.1.1 Fast implementation
The fast implementation for θ implies that, instead of optimising Eq. 29 we optimise the following problem:
θk = arg min
θk
∑
(i,j)∈I
(< V ij >Zˆk −f(αitij + βi; θk))
2 (36)
where < V ij >Zˆk is the mean value of the vertices belonging to cluster k. Mathematically, we define
Zˆk = [z1kγk, z2kγk, . . . , zLkγk] where γk = (
∑L
l=1 zlk)
−1 is the normalisation constant. Moreover, we have that
< V ij >Zˆk=
∑L
l=1 zlkγkV
ij . We take the derivative of the likelihood function lfast of the fast implementation
(Eq. 36) with respect to θk and perform several simplifications:
δlfast(θk|.)
δθk
=
δ
δθk
∑
(i,j)∈I
(
L∑
l=1
zlkγkV
ij − f(αitij + βi; θk)
)2
(37)
δlfast(θk|.)
δθk
=
∑
(i,j)∈I
2
((
L∑
l=1
γkzlkV
ij
)
− f(αitij + βi; θk)
)
−δf(.)
δθk
(38)
using the fact that
∑L
l=1 γkzlk = 1 we get:
δlfast(θk|.)
δθk
=
∑
(i,j)∈I
2
(
L∑
l=1
γkzlk
(
V ij − f(αitij + βi; θk)
)) −δf(.)
δθk
(39)
δlfast(θk|.)
δθk
= 2γk
∑
(i,j)∈I
−δf(.)
δθk
(
L∑
l=1
zlk
(
V ij − f(αitij + βi; θk)
))
(40)
By setting the derivative to zero, the optimal θ is thus a solution of the following equation:
∑
(i,j)∈I
−δf(.)
δθk
(
L∑
l=1
zlk
(
V ij − f(αitij + βi; θk)
))
= 0 (41)
5.1.2 Slow implementation
We will prove that if theta is a solution of the slow implementation, it is also a solution of Eq. 41, which
will prove that the fast implementation is equivalent. The slow implementation is finding θ from the following
equation:
θk = arg min
θk
L∑
l=1
zlk
∑
(i,j)∈I
(V ijl − f(αitij + βi; θk))2 (42)
Taking the derivative of the function above (lslow) with respect to θk we get:
δlslow(θk|.)
δθk
=
L∑
l=1
zlk
∑
(i,j)∈I
2(V ijl − f(αitij + βi; θk))
(
−δf(.)
δθk
)
= 0 (43)
After swapping terms around and using distributivity we get:
∑
(i,j)∈I
(
−δf(.)
δθk
) L∑
l=1
zlk(V
ij
l − f(αitij + βi; θk)) = 0 (44)
This is the same optimisation problem as in Eq. 41, which proves that the two formulations are equivalent
with respect to θ.
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5.2 Noise parameter - σ
The noise parameter σ can actually be computed in a closed-form solution for the original slow model im-
plementation, so there is no benefit in implementing the fast update for σ. Moreover, the σ in the fast
implementation computed the standard deviation in the mean value of the vertices within a certain cluster,
and not the deviation withing the actual value of the vertices.
5.3 Subjects-specific time shifts - α, β
5.3.1 Fast implementation
The equivalent fast formulation for the subject-specific time shifts is similar to the one for the trajectory
parameters. It should be noted however that we need to weight the sums corresponding to each cluster by γ−1k .
This gives the following equation for the fast formulation:
αi, βi = arg min
αi,βi
K∑
k=1
γ−1k
1
2σ2k
∑
j∈Ii
(< V ijl >Zˆk −f(αitij + βi; θk))
2 = 0 (45)
In order to prove that this is equivalent to the slow version, we need to take the derivative of the likelihood
function (lfast) from the above equation with respect to αi, βi and set it to zero:
δlfast(αi, βi|.)
δαi, βi
=
δ
δαi, βi
K∑
k=1
γ−1k
1
2σ2k
∑
j∈Ii
(< V ijl >Zˆk −f(αitij + βi; θk))
2 = 0 (46)
We expand the average across the vertices and slide the derivative operator inside the sums:
K∑
k=1
γ−1k
1
2σ2k
∑
j∈Ii
2
(
L∑
l=1
γkzlkV
ij
l − f(αitij + βi; θk)
)
−δf(.)
δαi, βi
(47)
Since
∑L
l=1 γkzlk = 1 we get:
2
K∑
k=1
γ−1k
1
2σ2k
∑
j∈Ii
−δf(.)
δαi, βi
(
L∑
l=1
γkzlk(V
ij
l − f(αitij + βi; θk))
)
(48)
Removing the factor 2 and sliding γk:
K∑
k=1
γ−1k γk
1
2σ2k
∑
j∈Ii
−δf(.)
δαi, βi
(
L∑
l=1
zlk(V
ij
l − f(αitij + βi; θk))
)
(49)
Further sliding
∑L
l=1 zlk to the left we get the final optimisation problem:
K∑
k=1
1
2σ2k
L∑
l=1
zlk
∑
j∈Ii
−δf(.)
δαi, βi
(V ijl − f(αitij + βi; θk)) (50)
5.3.2 Slow implementation
In a similar way to the trajectory parameters, we want to prove that solving the problem from Eq. 50 (fast
implementation) is the same as solving the original slow implementation problem, which is defined as:
αi, βi = arg min
αi,βi
L∑
l=1
K∑
k=1
zlk
1
2σ2k
∑
j∈Ii
(V ijl − f(αitij + βi; θk))2 (51)
Taking the derivative of the function above with respect to αi, βi, we get:
δlslow(αi, βi|.)
δαi, βi
=
K∑
k=1
1
2σ2k
L∑
l=1
zlk
∑
j∈Ii
−δf(.)
δαi, βi
(V ijl − f(αitij + βi; θk)) (52)
This is the same problem as the fast implementation one from Eq. 50, thus the fast model is equivalent to
the slow model with respect to α, β.
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